PropertyValue
?:abstract
  • Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic since March 2020. Diabetes mellitus, especially type 2 diabetes, has been linked to worse COVID-19-related outcomes. It has been shown that glycemic control is important in COVID-19 patients with diabetes. Individuals with well-controlled blood glucose levels had lower mortality compared to those with poor control, and glucose management might potentially influence the prognosis and outcomes of COVID-19 infection.
is ?:annotates of
?:creator
?:doi
  • 10.1111/jdi.13484
?:doi
?:journal
  • Journal_of_diabetes_investigation
?:license
  • cc-by
?:pmid
?:pmid
  • 33331120
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • Medline
?:title
  • Is metformin a miracle or a menace in COVID-19 patients with type 2 diabetes?
?:type
?:year
  • 2020-12-17

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/e6djyhta>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/e6djyhta>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all